Predicting enhanced cell killing through PARP inhibition

Molecular Cancer Research

Volumn 11, Issue 1, 2013, Pages 13-18

  Horton, Julie K ^a   Wilson, Samuel H ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 1,8 NAPHTHALIMIDE; 5' DOXYRIBOSE PHOSPHATE; DOUBLE STRANDED DNA; LYASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CELL KILLING; CYTOTOXICITY; DNA DAMAGE; DNA METHYLATION; EXCISION REPAIR; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; SENSITIZATION;

1-NAPHTHYLAMINE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; DNA DAMAGE; DNA REPAIR; ENZYME INHIBITORS; HUMANS; MICE; NAPHTHALIMIDES; NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; QUINOLONES;

EID: 84873054943     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-12-0512     Document Type: Review

References (21)

1. Anders CK, Winer EP, Ford JM, Dent R, Silver DP, Sledge GW, et al. Poly(ADP-ribose) polymerase inhibition: "Targeted" therapy for triplenegative breast cancer. Clin Cancer Res 2010;16:4702-10.
2. Beard WA, Wilson SH. Structure and mechanism of DNA polymerase b. Chem Rev 2006;106:361-82.
3. Horton JK, Watson M, Stefanick DF, Shaughnessy DT, Taylor JA, Wilson SH. XRCC1 and DNA polymerase b in cellular protection against cytotoxic DNA single-strand breaks. Cell Res 2008;18:48-63.
4. De Vos M, Schreiber V, Dantzer F. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochem Pharmacol 2012;84:137-46.
5. Lavrik OI, Prasad R, Sobol RW, Horton JK, Ackerman EJ, Wilson SH. Photoaffinity labeling of mouse fibroblast enzymes by a base excision repair intermediate. Evidence for the role of poly(ADP-ribose) polymerase- 1 in DNA repair. J Biol Chem 2001;276:25541-8.
6. Cistulli C, Lavrik OI, Prasad R, Hou E, Wilson SH. AP endonuclease and poly(ADP-ribose) polymerase-1 interact with the same base excision repair intermediate. DNA Repair (Amst) 2004;3:581-91.
7. Chalmers AJ. The potential role and application of PARP inhibitors in cancer treatment. Br Med Bull 2009;89:23-40.
8. Ruf A, de Murcia G, Schulz GE. Inhibitor and NAD binding to poly (ADP-ribose) polymerase as derived from crystal structures and homology modeling. Biochemistry 1998;37:3893-900.
9. Horton JK, Stefanick DF, Naron JM, Kedar PS, Wilson SH. Poly(ADPribose) polymerase activity prevents signaling pathways for cell cycle arrest following DNA methylating agent exposure. J Biol Chem 2005;280:15773-85.
10. Ahmad R, Rasheed Z, Ahsan H. Biochemical and cellular toxicology of peroxynitrite: implications in cell death and autoimmune phenomenon. Immunopharmacol Immunotoxicol 2009;31:388-96.
11. Sobol RW, Horton JK, Kuhn R, Gu H, Singhal RK, Prasad R, et al. Requirement of mammalian DNA polymerase-b in base-excision repair. Nature 1996;379:183-6.
12. Horton JK, Joyce-Gray DF, Pachkowski BF, Swenberg JA, Wilson SH. Hypersensitivity of DNA polymerase b null mouse fibroblasts reflects accumulation of cytotoxic repair intermediates from site-specific alkyl DNA lesions. DNA Repair (Amst) 2003;2:27-48.
13. Sobol RW, Kartalou M, Almeida KH, Joyce DF, Engelward BP, Horton JK, et al. Base excision repair intermediates induce p53- independent cytotoxic and genotoxic responses. J Biol Chem 2003;278:39951-9.
14. Sobol RW, Prasad R, Evenski A, Baker A, Yang X-P, Horton JK, et al. The lyase activity of theDNArepair protein b-polymerase protects from DNA-damage-induced cytotoxicity. Nature 2000;405:807-10.
15. Delaney CA, Wang L-Z, Kyle S, White AW, Calvert AH, Curtin NJ, et al. Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines. Clin Cancer Res 2000;6:2860-7.
16. Daniel RA, Rozanska AL, Thomas HD, Mulligan EA, Drew Y, Castelbuono DJ, et al. Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma. Clin Cancer Res 2009;15:1241-9.
17. Hecht SM. Bleomycin: new perspectives on the mechanism of action. J Nat Products 1999;63:158-68.
18. Horton JK, Baker A, Vande Berg BJ, Sobol RW, Wilson SH. Involvement of DNA polymerase b in protection against the cytotoxicity of oxidative damage. DNA Repair (Amst) 2002;1:317-33.
19. Ho TV, Scharer OD. Translesion DNA synthesis polymerases in DNA interstrand crosslink repair. Environ Mol Mutagen 2010;51:552-66.
20. Ewald B, Sampath D, Plunkett W. Nucleoside analogs: molecular mechanisms signaling cell death. Oncogene 2008;27:6522-37.
21. Cavanaugh NA, Beard WA, Wilson SH. DNA polymerase b ribonucleotide discrimination. J Biol Chem 2010;285:24457-65.